This DEFA14A filing is a placeholder or administrative submission with no substantive content. Monitor for a definitive proxy statement or other material filings that may contain shareholder meeting details or proposals.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 28 $22.14entry
- T+1 · 7mo ago −6.28%α −6.27% · $20.75
- T+5 · 7mo ago −5.24%α −6.93% · $20.98
- T+20 · 6mo ago −15.58%α −21.04% · $18.69
- T+60 · 4mo ago −11.11%α −15.10% · $19.68
Price Chart
How similar events traded
Executive Summary
Zai Lab Ltd filed a DEFA14A (additional definitive proxy soliciting materials) on April 28, 2026. The filing is a routine administrative submission with no material financial data, activist demands, or shareholder vote details provided in the available documents. No actionable financial impact or strategic change is discernible from this filing.
Key Facts
- Filed DEFA14A on April 28, 2026
- Filed by Zai Lab Ltd (registrant)
- No definitive proxy statement, preliminary proxy, or soliciting material content was available in the filing documents
- No financial figures, vote items, or activist demands were disclosed in the filing text
Financial Impact
No financial impact identified from the filing content
Risk Factors
- Lack of substantive content limits actionable insight
- No financial or strategic information to assess
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001704292-26-000032 |
| Document: 0001704292-26-000032-index-headers.html | 0001704292-26-000032 |
| Document: 0001704292-26-000032-index.html | 0001704292-26-000032 |
| Document: 0001704292-26-000032.txt | 0001704292-26-000032 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers